XI Republican Research-to-Practice Conference with International Participation “MULTIFACETED CARDIOLOGY. ADVANCES AND OPEN QUESTIONS”

XI Republican Research-to-Practice Conference with International Participation

“MULTIFACETED CARDIOLOGY. ADVANCES AND OPEN QUESTIONS”

02 March 2024

Astana city, Heydar Aliyev street 12,
Congress center

Registration Form

I will participate online.

I will participate in person.

Last Name

First Name

Patronymic (optional)

Specialization

Contact Phone

City

Country

Position

Work Place

Send me notifications when the conference starts

I Agree

Confirm your consent to the collection, processing of personal data.

I Agree

Logging in to the Website from other devices, please re-register!

Program

Opening of the Conference

09:00 - 09:05

Abseitova Saule Raimbekovna

Doctor of Medical Sciences, Associate Professor, Professor of the Department of Internal Medicine of South-Kazakhstan Academy of Medicine, Cardiologist of the highest qualification grade, Chairperson of the Board of the Republican Public Association “Kazakhstan Cardiology Society” of emergency care specialists, Member of the Presidium of the Association of Cardiologists of Kazakhstan, Member of the European Society of Cardiology

Opening. Welcome address

Plenary Meeting

Acute coronary syndrome. New paradigms and unchanged approaches

09:05 - 10:20

Moderators: Abseitova Saule Raimbekovna , Oilarova Tatyana Mikhailovna , Zhussupova Gyulnar Kairbekovna

09:05 - 09:20

Abseitova Saule Raimbekovna

“New paradigms and unchanged approaches to management of ACS patients”

09:20 - 09:30

Oilarova Tatyana Mikhailovna

Clinical Auditor of the Supervisory Board from MP No. 4

“What are the achievements and are there any open questions in the treatment of ACS patients”

09:30 - 10:00

Bedelbayeva Gulnara Gabdualiyevna

Doctor of Medical Sciences, Professor, Asfendiyarov KazNMU

“Key steps in management of patients with ACS and A-Fib”

Supported by Abdi-Ibrahim Global Pharm

10:00 - 10:10

Zhussupova Gyulnar Kairbekovna

Doctor of Medical Sciences, Associate Professor, Cardiologist of Pro Clinique MC

Draft protocol on ACS from RPA “Kazakhstan Cardiology Society”

10:10 - 10:20

Discussion. Questions and Answers

Questions for discussion: preliminary antiplatelet therapy to whom? When? Alternative antiplatelet therapy Multivascular stenting/ complete myocardial revasculization in elderly patients with ACS? Interventions for type 2 myocardial infarction Pregnancy and ACS

Atherosclerosis and dyslipidaemias. Don't miss opportunities...

10:20 - 11:20

Moderators: Abseitova Saule Raimbekovna , Karabayeva Raushan Zhumartovna

10:20 - 10:50

Karabayeva Raushan Zhumartovna

Doctor of Medical Sciences, Associate Professor, Deputy Director for clinical care of RSE “Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan”

“It is time to make innovations in dyslipidemia our daily practice as soon as today. Why wait?”

Supported by NOVARTIS

10:50 - 11:10

Zhussupova Gyulnar Kairbekovna

Doctor of Medical Sciences, Associate Professor, Cardiologist of Pro Clinique MC

“Innovative possibilities of secondary prevention of Cardiovascular complications. Place of polypills”

Supported by Acino

11:10 - 11:20

Discussion. Questions and Answers

Questions for discussion: Myths of statin therapy Primary prevention of dyslipidaemia, management of dyslipidaemia in ACS. How relevant is the problem of intolerance to statins? Combination lipid-modifying therapy, when, to whom? New targets in dyslipidaemia: lipoprotein (a), does it need to be determined for everyone, is there a possibility of correction? Is there a problem of familial hypercholesterolemia in Kazakhstan population?

11:20 - 11:40

Coffee break

Arterial hypertension. What is new and what has changed in the recommendations on arterial hypertension of the European Society of Hypertension 2023?

11:40 - 12:10

Moderators: Junusbekova Gulnar Aldeshovna , Zhussupova Gyulnar Kairbekovna

11:40 - 12:00

Junusbekova Gulnar Aldeshovna

Doctor of Medical Sciences, Associate Professor, Professor of the Department of Cardiology of Asfendiyarov KazNMU NCJSC, President of the “Society of Specialists in Arterial Hypertension and Cardiovascular Prevention” PA

“Current challenges and management of young and middle-aged arterial hypertension: ESH 2023 Guidelines”

Supported by Acino

12:00 - 12:10

Discussion. Questions and Answers

Questions for discussion: Measurement and monitoring of BP by different methods and in different conditions. New risk factors for AH. New in the assessment of target organ damage and CVD risk. Secondary forms of AH: updated description. News in non-drug and drug treatment of AH. Return of renal denervation in the treatment of resistant AH. New in the management of AH with comorbidities

Cardiac failure. Significant advances in recent years and problems of actual practice

12:10 - 13:15

Moderators: Abseitova Saule Raimbekovna , Oilarova Tatyana Mikhailovna

12:10 - 12:30

Villevalde Svetlana Vadimovna

Doctor of Medical Sciences, Professor, Head of the Analysis and Perspective Planning Service of the Administration for Federal Projects Implementation, Head of the Department of Cardiology at the Institute of Medical Education of V. A. Almazov National Medical Research Centre of the Ministry of Health of Russia FSBI (St. Petersburg)

“CHF 2024 - time for change”

Supported by AstraZeneca

12:30 - 12:50

Tereshina Olga Vladimirovna

Candidate of Medical Sciences, Assistant Professor Royal Brompton Hospital, London

“Heart failure with preserved ejection fraction. Opportunities and limitations of echocardiography”

12:50 - 13:05

Abseitova Saule Raimbekovna

“Remote dielectric study (ReDS) in diagnostics and monitoring of the volume status of patients with CHF”

Supported by Green Leaf Pharma

13:05 - 13:15

Discussion. Questions and Answers

Questions for discussion: Possibilities of prescribing quadrupletherapy for CHF with low EF in patients with CKD, on hemodialysis. Is there a priority in choosing a drug that affects the RAS system? Management tactics for patients with CHF with improved ejection fraction greater than 50%, should the quadrupletherapy be continued? Do patients with moderately reduced EF need quadrupletherapy?

13:15 - 14:00

Lunch

Cardiorenal and renicardiac syndromes

14:00 - 14:30

Moderators: Junusbekova Gulnar Aldeshovna , Zhussupova Gyulnar Kairbekovna

14:00 - 14:20

Junusbekova Gulnar Aldeshovna

“A new era of cardiorenal ptotection”

Supported by Boehringer Ingelheim

14:20 - 14:30

Discussion. Questions and Answers

Questions for discussion: The problem of early diagnosis of CKD in Kazakhstan. Optimal target BP in CKD. New algorithms of treatment of AH in CKD in ESH 2023 Guidelines. Management of dyslipidaemia in patients with CKD. New classes of drugs for cardio- and nephroprotection in CKD. Managing cardiovascular risk in patients with CKD and diabetes

Advances and challenges of cardiac surgery in 2024

14:30 - 15:10

Moderators: Albazarov Adilzhan Baurzhanovich , Tuleutayev Rustem Mukhtarovich

14:30 - 14:45

Albazarov Adilzhan Baurzhanovich

Candidate of Medical Sciences, Cardiac Surgeon

“Ischaemic mitral valve, when and what to do...”

14:45 - 15:00

Tuleutayev Rustem Mukhtarovich

Candidate of Medical Sciences, Head of the Cardiac Surgery Department of “Research Institute of Cardiology and Internal Medicine” JSC

“Diagnosis and management of hypertrophic cardiomyopathy”

15:00 - 15:10

Discussion. Questions and Answers

Interventional cardiology

15:10 - 16:10

Moderators: Lobkov Dmitriy Vladimirovich , Joldasbekova Aliya Utepbayevna

15:10 - 15:40

Lobkov Dmitriy Vladimirovich

Chief Physician of the Regional Cardiological Center of Kostanay

“Advances of our cardiologists in the Diagnosis and management of CHD during 2023. Stent, drug-coated balloon or scaffold. What to choose? Comorbid patient. Chronic coronary occlusive disease. What to do if the cardiac surgeon denied CABG?”

15:40 - 16:00

Joldasbekova Aliya Utepbayevna

Doctor of Medical Sciences, Chief Cardiologist of the Medical Center of the Administration of the President of the Republic of Kazakhstan

“A reliable strategy for controlling risk factors in patients with ACS - time to choose”

Supported by AstraZeneca

16:00 - 16:10

Discussion. Questions and Answers

Questions for discussion: place of CT-angiography in patients with ACS - For whom, when? Complete revascularization in multivessel lesions in patients with ACS. Features of interventional management of patients with non-obstructive myocardial infarction

Plenary Meeting

The time has come for a paradigm shift in the management of patients with stable chronic ischemic heart disease. Expert recommendations and real-world practice

16:10 - 17:10

Moderators: Abseitova Saule Raimbekovna , Zhussupova Gyulnar Kairbekovna , Sunkarbekova Zhanat Yessimovna

16:10 - 16:30

Zhussupova Gyulnar Kairbekovna

Doctor of Medical Sciences, Associate Professor, Cardiologist of Pro Clinique MC

“Review of recommendations on chronic coronary heart disease”

16:30 - 16:45

Zhussupova Gyulnar Kairbekovna

Doctor of Medical Sciences, Associate Professor, Cardiologist of Pro Clinique MC

“High-sensitive troponin I as a marker of risk of developing of coronary vascular diseases”

Supported by OLYMP

16:45 - 17:00

Sunkarbekova Zhanat Yessimovna

Cardiologist of the highest qualification grade, Assistant of the MUA Department of Cardiology, Director of Astana Branch of “Kazakhstan Cardiology Society” RPA

“Metabolic therapy is an effective tool for myocardial protection”

Supported by Claus Marsh

17:00 - 17:10

Discussion. Questions and Answers

Questions for discussion: Drug therapy or aggressive treatment! Non-obstructive CHD (INOCA). Importance of anatomical and functional significance assessment of obstructive lesion of coronary arteries in chronic ischemic heart disease? Possibilities in Kazakhstan to use modern methods of functional assessment of coronary blood flow. Is it necessary to prescribe beta-blockers to all patients with chronic ischemic heart disease? Are there any peculiarities of the course of chronic ischemic heart disease in women? Aspirin or other antiplatelet drugs in the management of patients with chronic ischemic heart disease?

17:10 - 17:20

Organisational issues. Closing of the Conference

Speakers

Abseitova Saule Raimbekovna

Albazarov Adilzhan Baurzhanovich

Candidate of Medical Sciences, Cardiac Surgeon

Bedelbayeva Gulnara Gabdualiyevna

Doctor of Medical Sciences, Professor, Asfendiyarov KazNMU

Villevalde Svetlana Vadimovna

Joldasbekova Aliya Utepbayevna

Doctor of Medical Sciences, Chief Cardiologist of the Medical Center of the Administration of the President of the Republic of Kazakhstan

Junusbekova Gulnar Aldeshovna

Zhussupova Gyulnar Kairbekovna

Doctor of Medical Sciences, Associate Professor, Cardiologist of Pro Clinique MC

Karabayeva Raushan Zhumartovna

Doctor of Medical Sciences, Associate Professor, Deputy Director for clinical care of RSE “Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan”

Lobkov Dmitriy Vladimirovich

Chief Physician of the Regional Cardiological Center of Kostanay

Oilarova Tatyana Mikhailovna

Clinical Auditor of the Supervisory Board from MP No. 4

Sunkarbekova Zhanat Yessimovna

Cardiologist of the highest qualification grade, Assistant of the MUA Department of Cardiology, Director of Astana Branch of “Kazakhstan Cardiology Society” RPA

Tereshina Olga Vladimirovna

Candidate of Medical Sciences, Assistant Professor Royal Brompton Hospital, London

Tuleutayev Rustem Mukhtarovich

Candidate of Medical Sciences, Head of the Cardiac Surgery Department of “Research Institute of Cardiology and Internal Medicine” JSC

Partners

gold sponsor

SILVER SPONSORS

BRONZE SPONSOR

Sponsors